Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G/A for TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX).
- Disclosed ownership: 3.1%.
- Date of event: 31 Mar 2026.
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 3.1% ownership in TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX) on 31 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 3.1% | 533,965 | 0 | 533,965 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 3.1% | 533,965 | 0 | 533,965 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 3.1% | 533,965 | 0 | 533,965 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |